α-Synuclein pathology as a target in neurodegenerative diseases

Goedert, M. & Spillantini, M. G. Lewy body diseases and multiple system atrophy as α-synucleinopathies. Mol. Psychiatry 3, 462–465 (1998).

Article  CAS  PubMed  Google Scholar 

Baba, M. et al. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson’s disease and dementia with Lewy bodies. Am. J. Pathol. 152, 879–884 (1998).

CAS  PubMed  PubMed Central  Google Scholar 

Wakabayashi, K., Yoshimoto, M., Tsuji, S. & Takahashi, H. α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. Neurosci. Lett. 249, 180–182 (1998).

Article  CAS  PubMed  Google Scholar 

Hamilton, R. L. Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using α-synuclein immunohistochemistry. Brain Pathol. 10, 378–384 (2000).

Article  CAS  PubMed  Google Scholar 

Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997).

Article  CAS  PubMed  Google Scholar 

Bi, M., Du, X., Jiao, Q., Chen, X. & Jiang, H. Expanding the role of proteasome homeostasis in Parkinson’s disease: beyond protein breakdown. Cell Death Dis. 12, 154 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng, C., Trojanowski, J. Q. & Lee, V. M. Protein transmission in neurodegenerative disease. Nat. Rev. Neurol. 16, 199–212 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sohrabi, T. et al. Common mechanisms underlying α-synuclein-induced mitochondrial dysfunction in Parkinson’s disease. J. Mol. Biol. 435, 167992 (2023).

Article  CAS  PubMed  Google Scholar 

Stykel, M. G. & Ryan, S. D. Nitrosative stress in Parkinson’s disease. NPJ Parkinsons Dis. 8, 104 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Maroteaux, L., Campanelli, J. T. & Scheller, R. H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804–2815 (1988).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ueda, K. et al. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 11282–11286 (1993).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Twohig, D. & Nielsen, H. M. α-Synuclein in the pathophysiology of Alzheimer’s disease. Mol. Neurodegener. 14, 23 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Polymeropoulos, M. H. et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997).

Article  CAS  PubMed  Google Scholar 

Appel-Cresswell, S. et al. α-Synuclein p.H50Q, a novel pathogenic mutation for Parkinson’s disease. Mov. Disord. 28, 811–813 (2013).

Article  CAS  PubMed  Google Scholar 

Daida, K. et al. α-Synuclein V15A variant in familial Parkinson’s disease exhibits a weaker lipid-binding property. Mov. Disord. 37, 2075–2085 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gadhave, K. et al. α-Synuclein strain dynamics correlate with cognitive shifts in Parkinson’s disease. Preprint at bioRxiv https://doi.org/10.1101/2024.10.22.619694 (2024).

Hoffman-Zacharska, D. et al. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson’s disease. Parkinsonism Relat. Disord. 19, 1057–1060 (2013).

Article  PubMed  PubMed Central  Google Scholar 

Kruger, R. et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat. Genet. 18, 106–108 (1998).

Article  CAS  PubMed  Google Scholar 

Lesage, S. et al. G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459–471 (2013).

Article  CAS  PubMed  Google Scholar 

Pasanen, P. et al. Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol. Aging 35, 2180.e1–2180.e5 (2014).

Article  CAS  PubMed  Google Scholar 

Yoshino, H. et al. Homozygous α-synuclein p.A53V in familial Parkinson’s disease. Neurobiol. Aging 57, 248.e7–248.e12 (2017).

Article  CAS  PubMed  Google Scholar 

Zarranz, J. J. et al. The new mutation, E46K, of α-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol. 55, 164–173 (2004).

Article  CAS  PubMed  Google Scholar 

Chartier-Harlin, M. C. et al. α-Synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364, 1167–1169 (2004).

Article  CAS  PubMed  Google Scholar 

Singleton, A. B. et al. α-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003).

Article  CAS  PubMed  Google Scholar 

Lee, V. M. & Trojanowski, J. Q. Mechanisms of Parkinson’s disease linked to pathological α-synuclein: new targets for drug discovery. Neuron 52, 33–38 (2006).

Article  CAS  PubMed  Google Scholar 

McNaught, K. S. & Olanow, C. W. Protein aggregation in the pathogenesis of familial and sporadic Parkinson’s disease. Neurobiol. Aging 27, 530–545 (2006).

Article  CAS  PubMed  Google Scholar 

Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469–6473 (1998).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mezey, E. et al. α-Synuclein in neurodegenerative disorders: murderer or accomplice? Nat. Med. 4, 755–757 (1998).

Article  CAS  PubMed  Google Scholar 

Galvin, J. E., Giasson, B., Hurtig, H. I., Lee, V. M. & Trojanowski, J. Q. Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology. Am. J. Pathol. 157, 361–368 (2000).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujiwara, H. et al. α-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell. Biol. 4, 160–164 (2002).

Article  CAS  PubMed  Google Scholar 

Anderson, J. P. et al. Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 281, 29739–29752 (2006).

Article  CAS  PubMed  Google Scholar 

Shahmoradian, S. H. et al. Lewy pathology in Parkinson’s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099–1109 (2019).

Article  CA

Comments (0)

No login
gif